FORM 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

May 11, 2017

 

 

THE DOW CHEMICAL COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-3433   38-1285128

(State or other jurisdiction

of incorporation)

 

(Commission

file number)

 

(I.R.S. Employer

Identification No.)

2030 DOW CENTER, MIDLAND, MICHIGAN 48674

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: 989-636-1000

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of the Company was held on May 11, 2017 for the purposes of (i) electing 13 directors to hold office until the next annual meeting of stockholders; (ii) ratifying the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2017 fiscal year; (iii) holding an advisory vote to approve executive compensation; and (iv) holding an advisory vote on the frequency of future advisory votes to approve executive compensation.

All of management’s nominees for director as named in the Company’s Proxy Statement were elected by the votes set forth in the table below.

Election of Directors

 

     Votes For      Votes Against      Abstentions      Broker Non-
Votes
 

Ajay Banga

     857,305,507        9,213,543        4,212,368        157,564,263  

Jacqueline K. Barton

     832,233,138        32,907,832        5,590,448        157,564,263  

James A. Bell

     844,195,411        22,441,454        4,094,553        157,564,263  

Richard K. Davis

     764,660,979        102,023,466        4,046,973        157,564,263  

Jeff M. Fettig

     828,884,030        35,886,871        5,960,517        157,564,263  

Andrew N. Liveris

     806,730,204        57,195,398        6,805,816        157,564,263  

Mark Loughridge

     856,669,761        9,659,017        4,402,640        157,564,263  

Raymond J. Milchovich

     856,262,283        10,055,943        4,413,192        157,564,263  

Robert S. (Steve) Miller

     843,189,535        23,261,140        4,280,743        157,564,263  

Paul Polman

     843,241,767        23,290,627        4,199,024        157,564,263  

Dennis H. Reilley

     849,732,865        16,721,728        4,276,825        157,564,263  

James M. Ringler

     722,339,002        139,119,831        9,272,585        157,564,263  

Ruth G. Shaw

     833,089,893        33,837,440        3,804,085        157,564,263  

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2017 fiscal year was ratified by the votes set forth in the table below.

 

     Votes For      Votes Against      Abstentions      Broker Non-
Votes
 

Ratification of independent registered public accounting firm

     1,002,913,775        21,056,136        4,325,770        N/A  


The Company’s executive compensation was approved, on an advisory basis, by the votes set forth in the table below.

 

     Votes For      Votes Against      Abstentions      Broker Non-
Votes
 

Advisory vote to approve executive compensation

     757,782,491        104,064,876        8,884,051        157,564,263  

Stockholders voted, on an advisory basis, on the frequency of future advisory votes to approve executive compensation by the votes set forth in the table below.

 

     1 Year      2 Years      3 Years      Abstentions      Broker Non-
Votes
 

Frequency of future advisory votes to approve executive compensation

     773,958,713        4,876,595        86,012,866        5,883,244        157,564,263  

The Board of Directors has determined that the Company will continue holding advisory votes to approve executive compensation on an annual basis.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE DOW CHEMICAL COMPANY

Registrant

Date: May 15, 2017

 

/s/ AMY E WILSON

Amy E. Wilson

Corporate Secretary and

Associate General Counsel